193 related articles for article (PubMed ID: 37800652)
1. Novel cell-based strategies for immunomodulation in vascularized composite allotransplantation.
Siemionow M; Kulahci Y; Zor F
Curr Opin Organ Transplant; 2023 Dec; 28(6):431-439. PubMed ID: 37800652
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Schweizer R; Zhang W; Tsuji W; Waldner M; Solari MG; Marra KG; Rubin JP; Gorantla VS
Transplantation; 2017 Jan; 101(1):e1-e11. PubMed ID: 27893612
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous resolution of acute rejection and tolerance induction with IL-2 fusion protein in vascularized composite allotransplantation.
Jindal R; Unadkat J; Zhang W; Zhang D; Ng TW; Wang Y; Jiang J; Lakkis F; Rubin P; Lee WP; Gorantla VS; Zheng XX
Am J Transplant; 2015 May; 15(5):1231-40. PubMed ID: 25676865
[TBL] [Abstract][Full Text] [Related]
4. Sensitization and Desensitization in Vascularized Composite Allotransplantation.
Moris D; Cendales LC
Front Immunol; 2021; 12():682180. PubMed ID: 34456906
[TBL] [Abstract][Full Text] [Related]
5. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
[TBL] [Abstract][Full Text] [Related]
6. Vascularized composite allografts and solid organ transplants: similarities and differences.
Weissenbacher A; Hautz T; Pratschke J; Schneeberger S
Curr Opin Organ Transplant; 2013 Dec; 18(6):640-4. PubMed ID: 24126807
[TBL] [Abstract][Full Text] [Related]
7. Vascularized composite allotransplantation: towards tolerance and the importance of skin-specific immunobiology.
Leonard DA; Kurtz JM; Cetrulo CL
Curr Opin Organ Transplant; 2013 Dec; 18(6):645-51. PubMed ID: 24126805
[TBL] [Abstract][Full Text] [Related]
8. Cellular activation pathways and interaction networks in vascularized composite allotransplantation.
Knoedler L; Knoedler S; Panayi AC; Lee CAA; Sadigh S; Huelsboemer L; Stoegner VA; Schroeter A; Kern B; Mookerjee V; Lian CG; Tullius SG; Murphy GF; Pomahac B; Kauke-Navarro M
Front Immunol; 2023; 14():1179355. PubMed ID: 37266446
[TBL] [Abstract][Full Text] [Related]
9. Cell-Based Therapies Induce Tolerance of Vascularized Composite Allotransplants: A Systematic Review.
Eldaly AS; Avila FR; Torres-Guzman RA; Maita K; Garcia JP; Serrano LP; Ho O; Forte AJ
J Surg Res; 2024 Jun; 300():389-401. PubMed ID: 38851085
[TBL] [Abstract][Full Text] [Related]
10. Premise and promise of mesenchymal stem cell-based therapies in clinical vascularized composite allotransplantation.
Schweizer R; Gorantla VS; Plock JA
Curr Opin Organ Transplant; 2015 Dec; 20(6):608-14. PubMed ID: 26536421
[TBL] [Abstract][Full Text] [Related]
11. Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts.
Cwykiel J; Jundzill A; Klimczak A; Madajka-Niemeyer M; Siemionow M
Arch Immunol Ther Exp (Warsz); 2021 May; 69(1):13. PubMed ID: 33970329
[TBL] [Abstract][Full Text] [Related]
12. Novel Strategies in Transplantation: Genetic Engineering and Vascularized Composite Allotransplantation.
Kauke-Navarro M; Noel OF; Knoedler L; Knoedler S; Panayi AC; Stoegner VA; Huelsboemer L; Pomahac B
J Surg Res; 2023 Nov; 291():176-186. PubMed ID: 37429217
[TBL] [Abstract][Full Text] [Related]
13. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
[TBL] [Abstract][Full Text] [Related]
14. Challenges and opportunities in vascularized composite allotransplantation of joints: a systematic literature review.
Zhang L; Hoyos IA; Zubler C; Rieben R; Constantinescu M; Olariu R
Front Immunol; 2023; 14():1179195. PubMed ID: 37275912
[TBL] [Abstract][Full Text] [Related]
15. Large Animal Models of Vascularized Composite Allotransplantation: A Review of Immune Strategies to Improve Allograft Outcomes.
Matar AJ; Crepeau RL; Mundinger GS; Cetrulo CL; Torabi R
Front Immunol; 2021; 12():664577. PubMed ID: 34276656
[TBL] [Abstract][Full Text] [Related]
16. Composite tissue allotransplantation: opportunities and challenges.
Iske J; Nian Y; Maenosono R; Maurer M; Sauer IM; Tullius SG
Cell Mol Immunol; 2019 Apr; 16(4):343-349. PubMed ID: 30842628
[TBL] [Abstract][Full Text] [Related]
17. Cell therapy in vascularized composite allotransplantation.
Anggelia MR; Cheng HY; Lai PC; Hsieh YH; Lin CH; Lin CH
Biomed J; 2022 Jun; 45(3):454-464. PubMed ID: 35042019
[TBL] [Abstract][Full Text] [Related]
18. Adipose-derived cellular therapies in solid organ and vascularized-composite allotransplantation.
Stivers KB; Beare JE; Chilton PM; Williams SK; Kaufman CL; Hoying JB
Curr Opin Organ Transplant; 2017 Oct; 22(5):490-498. PubMed ID: 28873074
[TBL] [Abstract][Full Text] [Related]
19. Tolerance Induction in Vascularized Composite Allotransplantation-A Brief Review of Preclinical Models.
Huelsboemer L; Kauke-Navarro M; Reuter S; Stoegner VA; Feldmann J; Hirsch T; Kueckelhaus M; Dermietzel A
Transpl Int; 2023; 36():10955. PubMed ID: 36846605
[TBL] [Abstract][Full Text] [Related]
20. The Effect of MHC Antigen Matching Between Donors and Recipients on Skin Tolerance of Vascularized Composite Allografts.
Shanmugarajah K; Powell H; Leonard DA; Mallard C; Albritton A; Harrington E; Randolph MA; Farkash E; Sachs DH; Kurtz JM; Cetrulo CL
Am J Transplant; 2017 Jul; 17(7):1729-1741. PubMed ID: 28035752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
